Skip to main content

Table 2 Demographic and health characteristics

From: Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design

Characteristic

Parents (n = 50)

Adolescents (n = 54)

P-value

n

%

n

%

Child’s age (years), mean (SD)

7.6 (2.5)

13.5 (1.2)

<0.0001

Child of male sex

32

64.0

36

66.7

0.84

Parents born in Canada

27

54.0

31

57.4

0.84

Parental education

0.0255

  University or college degree/diploma

38

76.0

31

57.4

 

  Some university or college

7

14.0

8

14.8

 

  Completed high school or less

5

10.0

15

27.8

 

Family has a drug benefits plan

41

82.0

42

77.8

0.59

Annual household income ($ CDN)

0.43

  Less than $60,000

11

22.0

19

35.2

 

  $60,000 to $120,000

17

34.0

16

29.6

 

  Greater than $120,000

15

30.0

6

11.1

 

  Not sure or prefer not to respond

7

14.0

13

24.1

 

Asthma attacks in last 6 months, mean (SD)

2.6 (3.7)

1.8 (3.6)

0.29

History of other respiratory conditions

  Respiratory syncytial virus

8

16.0

1

1.9

0.0134

  Croup

15

30.0

5

9.3

0.0116

Symptom frequency in the last month

0.99

  None

13

26.0

16

29.6

 

  One to two times per month

14

28.0

15

27.8

 

  One to three times per week

14

28.0

15

27.8

 

  One to four times per day

7

14.0

7

13.0

 

  Other or missing

2

4.0

1

1.9

 

Night-time asthma symptoms in last month

31

62.0

26

48.1

0.20

≥1 family doctor visit in last 6 months

18

36.0

11

20.4

0.19

≥1 pediatrician visit in last 6 months

13

26.0

9

16.7

0.55

≥1 respiratory specialist visit in last 6 months

35

70.0

36

66.7

0.39

≥1 emergency room visit in last year

13

26.0

16

29.6

0.21

≥1 hospital admission in last year

3

6.0

7

13.0

0.18

Received asthma management or action plan

35

70.0

40

74.1

0.79

Exposed to second-hand smoke in public

6

12.0

10

18.5

0.42

Asthma medications used in last year

0.35

  BD monotherapy

2

4.0

4

7.4

 

  ICS monotherapy

4

8.0

1

1.9

 

  BD + ICS or BD + AL

25

50.0

33

61.1

 

  BD + ICS + AL

16

32.0

12

22.2

 

  Oral corticosteroid with or without other asthma medication

2

4.0

4

7.4

 

  Other

1

2.0

0

0.0

 
  1. Abbreviations: AL anti-leukotriene, BD bronchodilator, ICS inhaled corticosteroid, SD standard deviation. P value from t-test for continuous variables and Fishers Exact test for categorical variables. Significant results indicated in bold type